NEW YORK , Feb. 11, 2025 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own NeueHealth Inc. ("NEUE" or the "Company") (NYSE: NEUE) stock purchased on or before December 22 , 2024 . Levi & Korsinsky, LLP has commenced an investigation into potential breaches of fiduciary duty by the NEUE board of directors.
NEW YORK , Feb. 10, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: NeueHealth, Inc. (NYSE: NEUE)'s sale to an affiliate of New Enterprise Associates for $7.33 per share in cash. If you are a NeueHealth shareholder, click here to learn more about your rights and options.
NEW YORK CITY, NY / ACCESS Newswire / February 9, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE) and New Enterprise Associates ("NEA") (: ). Investors who purchased NeueHealth and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NEUE.
NEW YORK CITY, NY / ACCESS Newswire / February 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE) and New Enterprise Associates ("NEA") (: ). Investors who purchased NeueHealth and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NEUE.
LOS ANGELES, CA / ACCESS Newswire / January 29, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
NEW YORK CITY, NY / ACCESS Newswire / January 29, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE) and New Enterprise Associates ("NEA") (: ). Investors who purchased NeueHealth and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NEUE.
LOS ANGELES, CA / ACCESS Newswire / January 27, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
NEW YORK CITY, NY / ACCESS Newswire / January 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE) and New Enterprise Associates ("NEA") (: ). Investors who purchased NeueHealth and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NEUE.
LOS ANGELES, CA / ACCESS Newswire / January 26, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
LOS ANGELES, CA / ACCESS Newswire / January 25, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.